Syneron Medical Ltd. (ELOS) announced the commercial launch of the elure topical skin whitening products in several Asian markets. The company will sell these products through its dermatologists, beauty salons and spas in Asia from the first quarter of 2010.

The elure skin whitening product is an enzymatic skin whitening treatment that targets and decomposes melanin to reveal a visibly lighter and exceptionally luminous skin tone. The product uses a naturally occurring bio-active substance, Melanozyme, which decomposes the melanin in a fast and safe manner with no side effects.

In the process, Melanozyme is combined with a bio-activator to diminish the dark colored pigment in the skin. The use of Melanozyme eliminates side effects such as skin redness and burning sensation which are seen in the case of other skin whitening products available in the market.

It has been estimated that skin whitening is one of the fastest growing segments of the global beauty industry. The global whitening market is expected to grow over 10% annually. In particular, the Asian market is estimated to be roughly $18 billion per annum in size and is expected to grow rapidly.

Headquartered in Yokneam Illit, Israel, Syneron Medical was founded in 2000 and is engaged in the design, development, and marketing of aesthetic medical products based on its proprietary electro-optical synergy (ELOS) technology. Its medical aesthetic devices are powered by proprietary software, and use the combined-energy technology of bi-polar radio frequency (RF) and optical energy (laser or non-coherent light).

Zacks Investment Research

1. (NUS) Nu Skin Enterprises – ROE of 25% Dwarfs the Industry Average of 6%Nu Skin Enterprises (NUS) recently posted record results for the third quarter. Earnings per share...
2. (ELOS) Syneron Medical to Acquire Primaeva MedicalSyneron Medical Ltd. (ELOS) is set to acquire Primaeva Medical, Inc., an aesthetic technology firm...
3. (ELOS) Syneron Medical Ltd to Purchase CandelaYesterday, Syneron Medical Ltd (ELOS) announced that it would buy Candela Corp. (CLZR) in a...
4. (CAH) Cardinal Health Sees Positive Results for Skin Preparation DrugCardinal Health Inc. (CAH) announced that the use of the preoperative skin preparation, ChloraPrep, is...
5. (NUS) Nu Skin Enterprises – Growth And Income – Zacks Rank BuyNu Skin Enterprises (NUS) recently declared a quarterly dividend of $0.115 per share, noting that...
6. (NUS) Nu Skin Enterprises, Inc. – Value – Zacks Rank BuyNu Skin Enterprises, Inc. (NUS) is playing the youth revolution as sales of its anti-aging...

Search Posts by Tag: ELOS | Syneron Medical Limited | Healthcare | Medical Appliances & Equipment

RSS Feeds by Tag: ELOS | Syneron Medical Limited | Healthcare | Medical Appliances & Equipment |

Other Posts by: vitalstocks | RSS Feed for this author